Bristol Myers Squibb Building Life Science Industry’s Most Advanced AI Factory on NVIDIA Vera Rubin

Bristol Myers Squibb is expanding its computational infrastructure by deploying a new AI cluster built on the NVIDIA Vera Rubin architecture. This expansion aims to enhance the company's existing life sciences research capabilities, which already utilize large-scale AI modeling. By scaling its processing power, the firm intends to accelerate its drug discovery pipeline and increase the efficiency of its pharmaceutical development operations.